(Q53929022)

English

Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning. (English)

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

cystic fibrosis

0 references

author name string

A Redmond

1

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

L Sweeney

2

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

M MacFarland

3

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

M Mitchell

4

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

S Daggett

5

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

R Kubin

6

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

publication date

1 December 1998

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

Journal of International Medical Research

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

26

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

6

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

304-312

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group

1 reference

https://api.crossref.org/works/10.1177%2F030006059802600604

21 January 2018

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group

1 reference

https://api.crossref.org/works/10.1177%2F030006059802600604

21 January 2018

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1177%2F030006059802600604

21 January 2018

Safety and efficacy of ciprofloxacin in paediatric patients--review

1 reference

https://api.crossref.org/works/10.1177%2F030006059802600604

21 January 2018

Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report

1 reference

https://api.crossref.org/works/10.1177%2F030006059802600604

21 January 2018

Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones

1 reference

https://api.crossref.org/works/10.1177%2F030006059802600604

21 January 2018

Identifiers

10.1177/030006059802600604

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10399112

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53929022&oldid=908401905"